◼ Archived
World
Pharmaceutical lobby sues Trump administration over most favored nation pricing
The pharmaceutical lobby group has launched a lawsuit against the Trump administration over most favored nation drug pricing policies.
3 trends tracked about this subject — the full history, oldest to newest below.
The pharmaceutical lobby group has launched a lawsuit against the Trump administration over most favored nation drug pricing policies.
A major setback for a promising cholesterol drug has cast doubt on a multibillion-dollar race to revolutionize heart health treatments.
AstraZeneca shares have declined following reports of potential $400 billion merger talks with Bristol Myers Squibb.